Share Issue News
Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.
Oct 24, 2025 at 4:00 PM
Salesforce Grants Equity Awards to Bluebirds and Waii Employees Under Its Inducement Equity Incentive Plan
SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the #1 AI CRM, today announced it has granted equity awards under its 2014 Inducement Equity Incentive Plan (the "Plan") to new employees who joined Salesforce in connection with the acquisitions of Bluebirds and Waii. The Plan was adopted by the Salesforce Board of Directors in July 2014, in accordance with New York Stock Exchange Rule 303A.08. Under the Plan, Salesforce granted a total of 42,844 restricted stock units ("RSUs") to 7 emplo...
Oct 23, 2025 at 4:31 PM
Coya Therapeutics Announces Proposed Public Offering of Common Stock
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common...
Oct 23, 2025 at 4:15 PM
GigCapital8 Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Rights Commencing October 27, 2025
PALO ALTO, Calif.--(BUSINESS WIRE)--GigCapital8 Corp. (NASDAQ: GIWWU) (the “Company”), a Cayman Islands exempted company, announced today that holders of the Company’s public units may elect to separately trade the Class A ordinary shares and rights underlying such public units commencing on October 27, 2025. Each unit consists of one Class A ordinary share and one right to receive one-fifth of one Class A ordinary share. Each five rights entitles the holder to receive one Class A ordinary shar...
Oct 21, 2025 at 11:10 PM
AST SpaceMobile Prices Repurchase of Convertible Senior Notes to be Funded By Concurrent Registered Direct Offering of Class A Common Stock
MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced the pricing of a cash repurchase (the “Repurchase”) of $50.0 million aggregate principal amount of its 4.25% convertible senior notes due 2032 (the “Existing Notes”) and its offering of approximately 2.0 millio...
Oct 21, 2025 at 5:36 PM
Owlet, Inc. Announces Proposed Public Offering of Class A Common Stock
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a proposed underwritten public offering of its Class A common stock (the “Offering”). In addition, Owlet intends to grant the underwriters a 30-day option to purchase additional shares of its Class A common stock in an amount up to 15% of the shares offered in the Offering, at the public offering price per share less underwriting discounts and commissions. Al...
Oct 21, 2025 at 1:53 PM
Primaris REIT Announces Closing of Over-Allotment Option
TORONTO--(BUSINESS WIRE)--Primaris Real Estate Investment Trust (“Primaris” or the “Trust”) (TSX: PMZ.UN) announced today the closing of the issuance of an additional 1,448,599 trust units of Primaris (“Units”) for gross proceeds of approximately $21.4 million. The issuance was pursuant to the exercise in full by the underwriters of their over-allotment option with respect to the Trust’s recently completed public offering of 10,000,000 Units on October 10, 2025 (the “Offering”). The exercise of...
Oct 20, 2025 at 10:45 PM
BlackRock Income Trust, Inc. (BKT) Announces Results of its Over-subscribed Rights Offering
NEW YORK--(BUSINESS WIRE)--BlackRock Income Trust, Inc. (NYSE: BKT) (the "Fund") today announced the successful completion of its transferable rights offer (the “Offer”) which expired on October 20, 2025 (the “Expiration Date”). The Offer entitled rights holders to subscribe for up to an aggregate of 8,097,238 shares of the Fund’s common stock, par value of $0.01 per share (each, a “Common Share”). The final subscription price of $10.76 per Common Share was determined based upon the formula equ...
Oct 20, 2025 at 5:32 PM
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards on (i) October 17, 2025, covering an aggregate of 1,579,500 shares of its common stock, consisting of stock options to purchase an aggregate of 1,553,000 shares of common stock, and restricted stock units (“RSUs”) representing an aggregate of 26,500 shares of common stock, to three newly hired employees and (ii) October 20, 2025,...
Oct 20, 2025 at 8:00 AM
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the closing of its previously announced private placement (https://investors.adagiomedical.com/news-releases/news-release-details/adagio-medical-announces-pricing-50-million-private-placement), led by existing investors and new healthcare-dedicated institutional investors....
Oct 17, 2025 at 4:15 PM
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance musculoskeletal health, today announced that the company granted inducement equity awards covering an aggregate of 114,500 shares of its common st...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.